Ask AI
Bill116th CongressFiled Oct 18, 2019Health
H.R. 4764

TRANSPLANT Act of 2020

Bill journey · stage 1 of 5

Just introduced

Filed
Comm.
Floor
Both
Law

What it doesSummary passed senate (Dec 11, 2020)

Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2020 or the TRANSPLANT Act of 2020

This bill modifies and reauthorizes through FY2025 the C.W. Bill Young Cell Transplantation Program, which provides support to patients who need a potentially life-saving bone marrow transplant or umbilical cord blood transplant. It also requires research and other activities related to stem cell therapies.

Specifically, the Department of Health and Human Services must conduct a periodic review of the science of using adult stem cells and birthing tissues in therapeutic treatments, and the National Institutes of Health must continue efforts to further the field of regenerative medicine using adult stem cells.

In addition, the Government Accountability Office must examine various issues related to the regenerative medicine workforce.

What just happenedDec 14, 2020

Message on Senate action sent to the House.

Who’s behind it

Rep. Matsui, Doris O. [D-CA-6](D-CA)Sponsor
52 cosponsors40 D12 R
Read on Congress.gov
52cosponsors1committees22actions1amendments2related bills9subjects
  1. Dec 14, 2020Floor

    Message on Senate action sent to the House.

  2. Dec 11, 2020Floor

    Passed Senate with an amendment by Voice Vote. (text of amendment in the nature of a substitute: CR S7450-7451)

  3. Dec 11, 2020Floor17000

    Passed/agreed to in Senate: Passed Senate with an amendment by Voice Vote.(text of amendment in the nature of a substitute: CR S7450-7451)

  4. Dec 11, 2020Floor

    Measure laid before Senate by unanimous consent. (consideration: CR S7450-7451)

  5. Oct 1, 2020IntroReferral

    Received in the Senate, read twice.

  6. Sep 30, 2020FloorH38310

    Motion to reconsider laid on the table Agreed to without objection.

  7. Sep 30, 2020FloorH37300

    On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 414 - 0 (Roll no. 211). (text: CR 09/29/2020 H4996)

  8. Sep 30, 2020Floor8000

    Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 414 - 0 (Roll no. 211).

  9. Sep 30, 2020FloorH30000

    Considered as unfinished business. (consideration: CR H5089-5090)

  10. Sep 29, 2020FloorH37220

    At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.

  11. Sep 29, 2020FloorH8D000

    DEBATE - The House proceeded with forty minutes of debate on H.R. 4764.

  12. Sep 29, 2020FloorH30000

    Considered under suspension of the rules. (consideration: CR H4996-4998)

  13. Sep 29, 2020FloorH30300

    Mr. Pallone moved to suspend the rules and pass the bill, as amended.

  14. Sep 29, 2020CalendarsH12410

    Placed on the Union Calendar, Calendar No. 449.

  15. Sep 29, 2020CommitteeH12200

    Reported by the Committee on Energy and Commerce. H. Rept. 116-549.

    Energy and Commerce Committee
  16. Sep 29, 2020Committee5000

    Reported by the Committee on Energy and Commerce. H. Rept. 116-549.

    Energy and Commerce Committee
  17. Sep 9, 2020Committee

    Ordered to be Reported by Voice Vote.

    Energy and Commerce Committee
  18. Sep 9, 2020Committee

    Committee Consideration and Mark-up Session Held.

    Energy and Commerce Committee
  19. Oct 21, 2019Committee

    Referred to the Subcommittee on Health.

    Health Subcommittee
  20. Oct 18, 2019IntroReferralH11100

    Referred to the House Committee on Energy and Commerce.

    Energy and Commerce Committee
  21. Oct 18, 2019IntroReferralIntro-H

    Introduced in House

  22. Oct 18, 2019IntroReferral1000

    Introduced in House

Passed SenateDec 11, 202055

Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2020 or the TRANSPLANT Act of 2020

This bill modifies and reauthorizes through FY2025 the C.W. Bill Young Cell Transplantation Program, which provides support to patients who need a potentially life-saving bone marrow transplant or umbilical cord blood transplant. It also requires research and other activities related to stem cell therapies.

Specifically, the Department of Health and Human Services must conduct a periodic review of the science of using adult stem cells and birthing tissues in therapeutic treatments, and the National Institutes of Health must continue efforts to further the field of regenerative medicine using adult stem cells.

In addition, the Government Accountability Office must examine various issues related to the regenerative medicine workforce.

Passed HouseSep 30, 202053

Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2020 or the TRANSPLANT Act of 2020

This bill modifies and reauthorizes through FY2025 the C.W. Bill Young Cell Transplantation Program, which provides support to patients who need a potentially life-saving bone marrow transplant or umbilical cord blood transplant. It also requires research and other activities related to stem cell therapies.

Specifically, the Department of Health and Human Services must conduct a periodic review of the science of using adult stem cells and birthing tissues in therapeutic treatments, and the National Institutes of Health must continue efforts to further the field of regenerative medicine using adult stem cells.

In addition, the Government Accountability Office must examine various issues related to the national blood stem cell workforce.

Reported to HouseSep 29, 20207

Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2019 or the TRANSPLANT Act of 2019

This bill modifies and reauthorizes through FY2025 the C.W. Bill Young Cell Transplantation Program, which provides support to patients who need a potentially life-saving bone marrow transplant or umbilical cord blood transplant. The bill also requires the Department of Health and Human Services to conduct a periodic review of the science of using adult stem cells and birthing tissues in therapeutic treatments.

Introduced in HouseOct 18, 2019

Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2019 or the TRANSPLANT Act of 2019

This bill modifies and reauthorizes through FY2025 the C.W. Bill Young Cell Transplantation Program, which provides support to patients who need a potentially life-saving bone marrow transplant or umbilical cord blood transplant. The bill also requires the Department of Health and Human Services to conduct a periodic review of the science of using adult stem cells and birthing tissues in therapeutic treatments.

TRANSPLANT Act of 2020 — Informed